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Trials of homocysteine lower-
ing should monitor iron status and 
correlate these data with outcomes. 
However, before such design modifica-
tions are implemented, it would be of great 
interest to assess the eff ects of induced iron 
depletion or defi ciency on homocysteine-
induced endothelial dysfunction. Details of 
the experimental design would diff er from 
those of Zheng et al.11 to allow for the non-
acute period of time required to induce 
iron depletion, for example by phlebotomy. 
As well as its potential importance to our 
understanding of the vasculopathic mecha-
nism of homocysteine, such a study might 
help to confi rm earlier work showing qual-
itative and quantitative similarities in the 
eff ects of iron chelation and iron depletion 
on oxidative stress in other experimental 
systems.16 Iron-dependent amplifi cation of 
the vasculotoxic eff ects of homocysteine, 
together with a possible ferritin-dependent 
increase in homocysteine concentration, 
may be one of several cooperating mecha-
nisms2,13,14,16–18 by which acquisition of 
stored iron increases cardiac risk.
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Fifty years of Balkan endemic 
nephropathy: daunting questions, 
elusive answers
V Batuman1
Balkan endemic nephropathy (BEN) has remained a geographically 
constant endemic for 50 years. Despite extensive research, its etiology 
remains unknown. In the current issue, in a study in one of the earliest 
sites where the endemic was first recognized, Dimitrov et al. confirm the 
persistance of the endemic into a new generation and also identify a 
maternal link in the pathogenesis of BEN. This intriguing finding needs 
to be confirmed in other endemic areas.
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Endemic occurrence of a serious kidney 
disease was fi rst recognized in the 1950s 
in geographically discrete areas along 
the Danube river and its tributaries in 
the Balkans, stretching into Romania, 
Bulgaria, Croatia, Serbia, and Bosnia-
Herzegovina.1–3 Th e disease has existed 
since at least the 1920s, and possibly for 
many decades earlier.3 Although much 
has been written about this tenacious 
endemic over the past 50 years, its pre-
cise etiology is still unknown.
Based on the criteria proposed by 
Danilovic4,5, there is little argument 
regarding the general features of Bal-
kan endemic nephropathy (BEN): a 
slowly progressive chronic tubulointer-
stitial disease that presents insidiously 
with signs of uremia during the fi ft h or 
sixth decade of life, occurring almost 
exclusively in farmers, oft en aff ecting 
multiple family members in a given 
household. Th e male-to-female distri-
bution is equal. Th e disease typically 
effects only those who have lived in 
an endemic area for at least 20 years. 
Individuals who leave an endemic area 
before age 20 are spared, whereas immi-
grants are likely to develop the disease 
15–20 years aft er settling in an endemic 
area, regardless of race or ethnicity.4
Clinically, the disease is character-
ized by tubular proteinuria, usually 
β2-microglobulinuria, profound ane-
mia, and absence of hypertension and 
edema.5 When investigated early dur-
ing its evolution, overt renal disease is 
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preceded by tubular dysfunction, includ-
ing salt wasting, Fanconi syndrome (i.e., 
amino aciduria, renal tubular acidosis, 
glycosuria, uricosuria), and tubular 
proteinuria. Urinalysis is usually unre-
markable; red blood cells and casts are 
often absent. One hallmark of BEN 
is low-molecular-weight proteinuria; 
among low-molecular-weight urinary 
proteins, detection of β2-microglobulin 
in the urine has been found to be use-
ful for identifying new cases of BEN 
and tracking both BEN suspects and 
patients at risk.4,5 Histologically, there 
is a paucity of infl ammatory cell infi l-
tration, extensive and severe fi brosis, 
and tubule atrophy. In advanced stages 
the kidneys are dramatically reduced in 
size, to as small as 2–3 cm, with smooth 
contours. Nearly half of aff ected patients 
also eventually develop papillary transi-
tional cell cancers in the renal pelvis and 
the ureters.4,6
The most striking aspect of the 
endemic is its discrete, stable geo-
graphic distribution (Figure 1). For the 
past 50 years, no new endemic foci have 
emerged, nor have any known endemic 
areas become non-endemic. Th e area 
covers approximately 20,000 km2 in 
the Balkans within a 500 km east-to-
west span (Figure 1). Th e endemic foci 
are scattered in a mosaic pattern, with 
endemic villages oft en located within 
2–3 km of non-endemic villages. Within 
an endemic village, certain households 
may have had nephropathy for genera-
tions, while neighboring households 
have had no recorded cases.1,2,4 (Dur-
ing a visit to one such village, a well-
known investigator of BEN remarked 
that he would know which house to live 
in for 50 years or more and not get the 
disease.) Th e discrete distribution of the 
endemic foci and the dwellings associ-
ated with BEN is reminiscent of a radon 
map from, for example, the northeastern 
United States. An epidemiological study 
conducted over 10 years ago accounted 
for some 25,000 cases and more than 
100,000 people at risk.7
Th e elusive etiology of BEN has been 
the subject of many studies. Given the 
geographic stability of the endemic, 
most research has focused on envi-
ronmental factors.1,3,4 Heavy metals, 
including lead, cadmium, and arsenic, 
have been eliminated as likely causes. 
Selenium defi ciency in water and soil 
was proposed as a potential etiology, but 
was found to be distributed uniformly 
among both endemic and non-endemic 
areas. Moreover, despite its association 
with cardiac disease in China, selenium 
defi ciency has never been convincingly 
linked to kidney disease and is highly 
improbable as a cause of BEN.
Many investigators have examined the 
role of nephrotoxic mycotoxins, includ-
ing ochratoxin A—a cause of porcine 
nephropathy in northern Europe, which 
can produce kidney disease in other 
experimental animals as well. However, 
the distribution of ochratoxin in endemic 
areas is seasonal and not diff erent from 
that in non-endemic areas, and no exam-
ples of kidney disease in humans have 
been described. Chinese herbs (used 
for weight loss) contaminated with the 
botanical nephrotoxin aristolochic acid 
can also cause severe kidney disease with 
extensive fi brosis, relatively little infl am-
matory cell infi ltration, and a very high 
incidence of urothelial cancers, resem-
bling BEN. However, unlike BEN, which 
progresses to end-stage kidney disease 
very slowly, aristolochic acid nephropa-
thy usually develops in less than a year. 
Furthermore, its easy mobility is incon-
sistent with the geographic constancy of 
the endemic.
Despite the occurrence of BEN across 
diverse ethnic and racial groups, a 
genetic explanation initially appeared 
compelling, based on the familial clus-
tering of the cases. Bulgarian research-
ers demonstrated a high frequency of 
spontaneous and induced (by X-ray 
and folic acid) aberrations and break-
age in several chromosome bands, most 
frequently 3q25.1,8 Interestingly, three 
additional bands with increased fre-
quency of aberrations in BEN patients 
contain oncogenes — 1q36-c src, 3p25 
raf-1, and 6q23 myb — possibly explain-
ing the increased incidence of urothelial 
cancers in BEN patients.4 Th ese chro-
mosomal aberrations are more likely 
to represent environmentally induced 
DNA injury or instability rather than a 
genetic predisposition.
Another avenue has been explored 
by geochemists from the US Geologi-
cal Survey and from Romania, who have 
determined that most of the endemic 
area lies over, or in close proximity to, 
Figure 1 | Map showing the distribution of endemic regions along the Danube and Sava 
rivers. Shaded areas represent clusters of endemic regions (adopted from ref. 12).
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low-rank Pliocene coal deposits. Water 
from shallow wells in endemic villages 
has also been found to contain soluble 
polar aromatic and polynuclear aro-
matic hydrocarbons, derived from the 
weathering of coal — including naph-
thylamine, aniline, anthracene, pyrene, 
and many other known carcinogens, 
which could also explain the link to 
urothelial cancers.9 These results are 
promising but inconclusive. Th e vast-
ness of the coal deposits underlying 
both the endemic and non-endemic 
areas again raises the question of how 
to explain the mosaic-like distribution 
of affl  icted settlements.
The consistent  f inding of  β2-
microglobulinuria in BEN patients led to 
the speculation that this protein may be 
more than a marker, and may play a role 
in the pathogenesis of the disease.3,10 
Continued cellular stress resulting 
from exposure to environmental toxic 
agents might result in pre-malignant 
expression and overproduction of β2-
microglobulin by urothelial cells, lead-
ing to protein-mediated kidney disease 
and the eventual neoplastic transfor-
mation of these cells — thus account-
ing for the high incidence of urothelial 
cancers.3,10 Th e HLA class I antigen β2-
microglobulin is a marker for urothelial 
tumors, and its production by urothelial 
cancer cells, both in vivo and in vitro, is 
oft en markedly elevated, supporting this 
hypothesis. However, this idea has not 
been fully explored.
In research reported in this issue, 
Dimitrov et al.11 studied the off spring 
of BEN patients in the Vratza district 
in Bulgaria. One of the earliest descrip-
tions of endemic nephritis came from 
this region, which was recognized 50 
years ago as an endemic focus. The 
authors have identifi ed renal tubular 
dysfunction, tubular proteinuria, β2-
microglobulinuria, decreased creatinine 
clearance, and small kidney sizes in the 
adult off spring of female but not male 
BEN patients. Th e mean age of these 
patients was 49, and 70% of the subjects 
were younger than 55. Th ese individuals 
must be considered early cases of BEN, 
and clearly document the persistence 
of BEN into a new generation, despite 
recent reports that the endemic may be 
waning.4 Th e authors’ novel and intrigu-
ing observations indicate a maternal 
association with BEN risk, suggesting 
that exposure to environmental toxins 
in utero might play a role in the patho-
genesis of the disease. If this is the case, 
it may imply an early ‘priming’ eff ect, 
which progresses to overt disease in 
adult life only with continued exposure 
for 15–20 years. At-risk individuals who 
leave the endemic regions before this 
period escape the disease. Th is is one 
of the rare studies that have uncovered 
a new aspect of the endemic, and the 
maternal connection should be pursued 
in other endemic areas.
In the 50 years since the recognition 
of BEN, certain possible culprits, such 
as heavy metals or infection, have been 
ruled out; but, excepting the present 
study by Dimitrov et al., no new ground 
has been broken. Much eff ort has been 
expended on retesting old, discarded 
hypotheses as newer research tools 
became available, rather than exploring 
newer hypotheses. Th e solution to the 
enigma of BEN is highly likely to yield 
valuable insights into the pathophysiol-
ogy of chronic tubulointerstitial kidney 
disease, while addressing a signifi cant 
cause of human suff ering in the endemic 
area. Clearly, any novel hypothesis must 
be reconciled with the static geography 
of the endemic. Th eoretical and prac-
tical benefi ts both warrant a concerted 
international effort to decipher this 
complex medical mystery.
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